Defziff 24 Tablet contains Deflazacort 24 mg, a corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is used for managing autoimmune disorders, chronic inflammatory conditions, and severe allergies, reducing tissue inflammation and immune overactivity.
Clinically, Deflazacort works by modulating the immune response and decreasing pro-inflammatory mediators, providing relief from symptoms such as joint pain, swelling, and allergic reactions. Its efficacy and tolerability make it suitable for long-term management under medical supervision.
The tablet formulation ensures accurate dosing, ease of administration, and consistent therapeutic effect, supporting hospitals, clinics, and outpatient care in the treatment of chronic inflammatory and autoimmune conditions.
From a business perspective, Defziff 24 Tablet is a high-demand corticosteroid, offering franchise partners strong market presence, repeat orders, and credibility in anti-inflammatory therapy.
Common side effects may include gastrointestinal discomfort, increased appetite, weight gain, mood changes, and fluid retention. Long-term use may lead to osteoporosis, hypertension, hyperglycemia, or adrenal suppression. Rarely, allergic reactions may occur.
Defziff 24 Tablet is indicated for the treatment of inflammatory and autoimmune disorders, including asthma, rheumatoid arthritis, systemic lupus erythematosus, chronic allergic conditions, and certain muscular dystrophies. It is also used for managing conditions requiring immunosuppression under medical supervision.
Use Defziff 24 Tablet strictly under medical supervision. Do not discontinue therapy abruptly, especially after long-term use, to avoid adrenal insufficiency. Inform your doctor of any history of infections, diabetes, hypertension, or liver/kidney disorders. Report unusual symptoms such as severe abdominal pain, persistent swelling, or vision changes immediately.
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.